Position in BIIB
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$21,606
+$3,273 QoQ
Shares Held
100
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#870
of 1,031 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BROADWATER CAPITAL MANAGEMENT LLC holds $13,165,231 across 9 Drug Manufacturers - General names. BIIB ranks #7 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
21,130 | $5,366,386 | |
| 2 | MRK |
Merck & Co., Inc.
|
29,582 | $3,801,287 | |
| 3 | ABBV |
AbbVie Inc.
|
12,957 | $3,260,499 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
6,545 | $377,122 | |
| 5 | PFE |
Pfizer Inc
|
10,117 | $243,617 | |
| 6 | NVS |
Novartis AG
|
370 | $57,986 | |
| 7 | BIIB |
Biogen Inc.
This page
|
100 | $21,606 | |
| 8 | AMGN |
Amgen Inc
|
58 | $21,002 |
All Filings in BIIB
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,606 | 100 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $18,333 | 100 | Shares | Sole | 2026-07-24 | |
| 2025-12-31 | $17,599 | 100 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $14,008 | 100 | Shares | Sole | 2026-02-03 | |
| 2025-06-30 | $12,559 | 100 | Shares | Sole | 2026-02-03 | |
| 2025-03-31 | $13,684 | 100 | Shares | Sole | 2026-02-03 | |
| 2024-12-31 | $15,292 | 100 | Shares | Sole | 2026-02-03 | |
| 2024-09-30 | $27,137 | 140 | Shares | Sole | 2026-02-03 | |
| 2024-06-30 | $32,454 | 140 | Shares | Sole | 2026-02-03 | |
| 2024-03-31 | $30,188 | 140 | Shares | Sole | 2026-02-03 | |
| 2023-12-31 | $36,227 | 140 | Shares | Sole | 2026-02-03 | |
| No filing history on record for this holder in this stock. | ||||||